Loading clinical trials...
Loading clinical trials...
Efficacy of the Oncoxin-Viusid® Oral Solution in Reducing the Adverse Reactions of Chemotherapy and Radiotherapy in Patients Diagnosed With Cervical Cancer and Endometrial Adenocarcinoma.
Conditions
Interventions
Oncoxin-Viusid®
Placebo
Locations
1
Cuba
Ramón González Coro Hospital
La Habana, Cuba
Start Date
January 7, 2015
Primary Completion Date
February 1, 2019
Completion Date
September 30, 2019
Last Updated
January 23, 2020
Lead Sponsor
Catalysis SL
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions